Scientists begin testing two coronavirus vaccines
Australian researchers reach ‘critical milestone’ in global Covid-19 battle
Scientists in Australia have begun testing two potential coronavirus vaccines, marking a “critical milestone” in the fight to bring the global pandemic under control.
The vaccines, made by Oxford University and US company Inovio Pharmaceutical, have been cleared for animal testing by the World Health Organization.
The first human trial for a coronavirus vaccine took place in the US last month, the BBC reports. But Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) says its tests will be the first pre-clinical trials of the vaccines using an animal model – in this case ferrets, which contract the coronavirus as humans do.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Guardian adds that approximately 35 companies and academic institutions around the world are currently racing to create a vaccine.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
“Normally it takes about one-to-two years to get to this point and we’ve in fact shortened that to a period of a couple of months,” Rob Grenfell from CSIRO told reporters.
“This unprecedented speed is thanks in large part to early Chinese efforts to sequence the genetic material of Sars-CoV-2, the virus that causes Covid-19,” says The Guardian.
“China shared that sequence in early January, allowing research groups around the world to grow the live virus and study how it invades human cells and makes people sick.”
Another factor is access to existing research combating similar viruses, particularly severe acute respiratory syndrome (Sars) and Middle East respiratory syndrome (Mers).
According to Yahoo Finance, scientists elsewhere are also trialling existing drugs used to treat conditions such as Ebola, HIV, malaria and tuberculosis in order to establish if they could be used against the coronavirus.
“The ideal vaccine would be safe, easy to administer, simple and cheap to manufacture, and provide long-term protection against Covid-19,” write Kylie Quinn and Damian Purcell on The Conversation.
“But, to begin with, we’d even be happy with a vaccine that could reduce the amount of virus generated during a typical infection. If an infected person is making less virus, they are less likely to infect others. Less virus could also reduce the amount of damage caused by an infection in the patient.”
The first results from animal tests could be revealed as early as June, scientists say, and if successful, the vaccines could then be moved into clinical trials that could be conducted at labs elsewhere.
“At that point, the race to get the medicine into the general market could be accelerated, but experts warn it would still involve a minimum 18-month timeline to meet regulatory tests and standards,” says the BBC.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
What the chancellor's pension megafund plans mean for your money
Rachel Reeves wants pension schemes to merge and back UK infrastructure – but is it putting your money at risk?
By Marc Shoffman, The Week UK Published
-
Why Māori are protesting in New Zealand
A controversial bill has ignited a 'flashpoint in race relations' as opponents claim it will undermine the rights of Indigenous people
By Richard Windsor, The Week UK Published
-
Crossword: November 21, 2024
The Week's daily crossword
By The Week Staff Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published